Gazyvaro 1000 mg/40 ml

Gazyvaro 1000 mg/40 ml is a medicine authorised by Swissmedic under authorisation number 63172. The authorisation holder is Roche Pharma (Schweiz) AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 10 June 2014 and the authorisation is valid without a time limit. ATC code L01FA03 places the medicine in the group Antineoplastic agents.

  • Dispensing category A
  • Authorisation number 63172
  • ATC L01FA03
  • Biotechnological medicines
Authorisation data
Authorisation number63172
NameGazyvaro 1000 mg/40 ml
Full nameGazyvaro 1000 mg/40 ml, Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderRoche Pharma (Schweiz) AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL01FA03
First authorisation10 June 2014
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Gazyvaro 1000 mg/40 ml, Konzentrat zur Herstellung einer InfusionslösungA10 June 2014

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L01FA0307.16.1.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Gazyvaro 1000 mg/40 ml authorised in Switzerland?

Yes. Gazyvaro 1000 mg/40 ml is authorised by Swissmedic under authorisation number 63172, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Gazyvaro 1000 mg/40 ml have?

Gazyvaro 1000 mg/40 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Gazyvaro 1000 mg/40 ml?

The authorisation holder is Roche Pharma (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com